Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
Go back to Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD| (NASDAQ: LQDA) | Delayed: 71.05 -4.28 (5.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.33 | 52 Week High | $ | |||
| Open | $73.55 | 52 Week Low | $ | |||
| Day High | $74.53 | P/E | N/A | |||
| Day Low | $70.85 | EPS | $ | |||
| Volume | 1,583,107 | |||||
